A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease. For patients with localized PDAC, surgery is the best option, but with a median survival of less than 2 years and a difficult and prolonged postoperative course for most, there is an urgent need to better identify patients who have th...

Full description

Bibliographic Details
Main Authors: Jeran K Stratford, David J Bentrem, Judy M Anderson, Cheng Fan, Keith A Volmar, J S Marron, Elizabeth D Routh, Laura S Caskey, Jonathan C Samuel, Channing J Der, Leigh B Thorne, Benjamin F Calvo, Hong Jin Kim, Mark S Talamonti, Christine A Iacobuzio-Donahue, Michael A Hollingsworth, Charles M Perou, Jen Jen Yeh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-07-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC2903589?pdf=render

Internet

http://europepmc.org/articles/PMC2903589?pdf=render

Similar Items